Histogen Reports Second Quarter 2020 Earnings and Provides Business Update
13 août 2020 16h05 HE
|
Histogen Inc
Completed Enrollment for HST-001 Phase 1a/2b Trial for Androgenic Alopecia in Men with Topline Data Expected 4Q20Filed IDE for HST-002 for Treatment of Moderate to Severe Nasolabial FoldsAppointed...
Histogen to Report Second Quarter 2020 Earnings on August 13, 2020
30 juil. 2020 16h15 HE
|
Histogen Inc
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite...
Histogen to Present at the Canaccord Genuity 40th Annual Growth Conference
29 juil. 2020 16h15 HE
|
Histogen Inc
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite...
Histogen Inc. Announces Common Stock Purchase Agreement for up to $10 Million with Lincoln Park Capital Fund, LLC
20 juil. 2020 16h10 HE
|
Histogen Inc
SAN DIEGO, July 20, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (“Histogen” or the “Company”) (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and...
Histogen Announces Completion of Patient Enrollment for its HST 001 Phase 1b/2a Trial for Androgenic Alopecia in Men
14 juil. 2020 05h00 HE
|
Histogen Inc
SAN DIEGO, July 14, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today...
Histogen to Present at BIO Digital 2020
03 juin 2020 08h00 HE
|
Histogen Inc
SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body,...
Histogen Announces First Patient Dosed in Phase 1b/2a Trial of HST 001 for Androgenic Alopecia
01 juin 2020 08h00 HE
|
Histogen Inc
SAN DIEGO, June 01, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body,...
Histogen Appoints Susan A. Knudson as Chief Financial Officer
28 mai 2020 08h00 HE
|
Histogen Inc
SAN DIEGO, May 28, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body,...
Histogen Announces Successful Completion of its Merger with Conatus Pharmaceuticals
27 mai 2020 08h00 HE
|
Histogen Inc
SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body,...